← Back to Search

Educational Intervention for HPV Vaccination

N/A
Recruiting
Led By Elisa Rodriguez
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
PARENT/GUARDIAN SURVEY: English speaking
Be older than 18 years old
Must not have
Individuals who are not yet adults (infants, children, teenagers)
Cognitively impaired adults/adults with impaired decision-making capacity
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years (60 months)
Awards & highlights
No Placebo-Only Group

Summary

This trial focuses on improving HPV vaccination rates in rural areas by implementing evidence-based strategies in primary care settings. The goal is to increase awareness and access to the HPV vaccine in these communities to prevent cancer effectively

Who is the study for?
This trial is for primary care settings in rural areas that are looking to improve their rates of HPV vaccination. The focus is on implementing a program called PC TEACH, which aims to educate and facilitate better vaccination practices.
What is being tested?
The study tests the effectiveness of an educational intervention known as PC TEACH designed to optimize HPV vaccine delivery in rural primary care. It evaluates how well this strategy works in increasing vaccination rates against human papillomavirus.
What are the potential side effects?
Since this trial involves an educational intervention rather than a medical treatment, there are no direct side effects associated with medications or vaccines. Indirect effects may include changes in clinic operations or patient-provider interactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a parent or guardian who speaks English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under the age of 18.
Select...
I have difficulty making decisions due to cognitive impairment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years (60 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years (60 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Adolescent HPV vaccination rates
Secondary study objectives
Age at vaccination

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Health services research (PC TEACH)Experimental Treatment1 Intervention
Primary practice providers sites receive PC TEACH over 3.5 hours for 12 months

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
443 Previous Clinical Trials
1,413,235 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,956 Previous Clinical Trials
41,112,067 Total Patients Enrolled
Roswell Park Cancer InstituteLead Sponsor
414 Previous Clinical Trials
33,706 Total Patients Enrolled
Elisa RodriguezPrincipal InvestigatorRoswell Park Cancer Institute
~11 spots leftby Apr 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top